Prime Medicine, Inc. Long-term assets (Other)

Long-term assets (Other) of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term assets (Other) growth rates and interactive chart. All other non-current assets that do not fit the categories above.

Highlights and Quick Summary

  • Long-term assets (Other) for the quarter ending September 30, 2023 was $15.3 Million (a 0.0% decrease compared to previous quarter)
  • Year-over-year quarterly Long-term assets (Other) increased by 1.12%
  • Annual Long-term assets (Other) for 2022 was $15.1 Million (a -2.93% decrease from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term assets (Other) of Prime Medicine, Inc.

Most recent Long-term assets (Other)of PRME including historical data for past 10 years.

Interactive Chart of Long-term assets (Other) of Prime Medicine, Inc.

Prime Medicine, Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $15.31 $15.31 $15.14
2022 $15.14 $19.11 $15.14
2021 $15.6

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology